Department of Oral Implantology and Prosthetic Dentistry, Academic Centre for Dentistry Amsterdam (ACTA), Research Institute MOVE, University of Amsterdam and VU University Amsterdam, Gustav Mahlerlaan 3004, 1081 LA Amsterdam, the Netherlands.
Department of Oral Implantology, Hospital/School of Stomatology, Zhejiang University, Yan'an Road 395, 310006, Hangzhou, China.
Sci Rep. 2017 Jan 31;7:41800. doi: 10.1038/srep41800.
Most materials used clinically for filling critical-sized bone defects (CSBD), such as deproteinized bovine bone (DBB), lack osteoinductivity so that their therapeutic effects are far from satisfactory. The effect of bone morphogenic protein 2 (BMP2)-coprecipitated biomimetic calcium phosphate granules (BMP2-cop.BioCaP) on osteoinduction of DBB graft(s) during CSBD healing is still unknown. We investigated whether BMP2-cop.BioCaP affects the osteoinductivity of DBB, bone formation, and foreign body reaction during CSBD healing. DBB + BMP2-cop.BioCaP, DBB, DBB + BMP2, DBB + BioCaP, and autologous bone grafts were implanted in the CSBD of sheep. Bone formation, DBB/BioCaP degradability, foreign body reaction, and osteoinductivity of DBB were analyzed histologically and histomorphometrically at week 4 and 8. Combination of BMP2-cop.BioCaP and DBB healed CSBD as effectively as autologous bone grafts. About 95% of the BMP2-cop.BioCaP had been degraded and replaced by new bone at week 8 in the DBB + BMP2-cop.BioCaP-group. Foreign body reaction was reduced in the DBB + BMP2-cop.BioCaP-group compared to the other groups. The independent use of the BMP2-cop.BioCaP did not achieve a satisfactory bone repair. In conclusion, the BMP2-cop.BioCaP showed good degradability and biocompatibility, and enhanced osteoinductivity of DBB during CSBD healing in sheep, suggesting BMP2-cop.BioCaP as a potential osteoinducer to enhance the therapeutic effects of the graft materials in clinic.
大多数临床上用于填充临界尺寸骨缺损(CSBD)的材料,如脱蛋白牛骨(DBB),缺乏成骨诱导性,因此其治疗效果远不理想。骨形态发生蛋白 2(BMP2)共沉淀仿生钙磷颗粒(BMP2-cop.BioCaP)对 CSBD 愈合过程中 DBB 移植物成骨的影响尚不清楚。我们研究了 BMP2-cop.BioCaP 是否影响 DBB 的成骨诱导作用、骨形成和 CSBD 愈合过程中的异物反应。将 DBB+BMP2-cop.BioCaP、DBB、DBB+BMP2、DBB+BioCaP 和自体骨移植物植入绵羊的 CSBD 中。在第 4 周和第 8 周,通过组织学和组织形态计量学分析骨形成、DBB/BioCaP 降解性、异物反应和 DBB 的成骨诱导性。BMP2-cop.BioCaP 与 DBB 的组合与自体骨移植物一样有效地治愈 CSBD。在 DBB+BMP2-cop.BioCaP 组中,约 95%的 BMP2-cop.BioCaP 在第 8 周已降解并被新骨取代。与其他组相比,DBB+BMP2-cop.BioCaP 组的异物反应减少。BMP2-cop.BioCaP 的独立使用并未达到令人满意的骨修复效果。综上所述,BMP2-cop.BioCaP 具有良好的降解性和生物相容性,可增强绵羊 CSBD 愈合过程中 DBB 的成骨诱导性,提示 BMP2-cop.BioCaP 作为一种潜在的成骨诱导剂,可增强临床中移植物材料的治疗效果。